In the present study, the plasma levels of long-chain ceramide C18:1 were inversely associated with insulin sensitivity (i.e., higher levels indicated greater insulin resistance), whereas levels of very-long-chain ceramide C26:0 were positively associated with insulin sensitivity. The gene discussed is INS; the disease is Insulin resistance.